Life science patents granted, by filing office in Monaco
Monaco: Life science patents granted, by filing office was 1 patents in 2023. ◆ Volatile
Life science patents granted, by filing office in Monaco, 1980–2023
Source: World Intellectual Property Organization (WIPO) (2025) – processed by Our World in Data. Measured in patents.
Analysis
The most recent figure for life science patents granted, by filing office in Monaco is 1 patents, measured in 2023.
Compared with earlier readings it is unchanged over ten years.
Over the whole period, life science patents granted, by filing office in Monaco peaked at 25 patents in 1989 and was at its lowest, 0 patents, in 1999.
That places Monaco 46th out of 70 countries with data for 2023, putting it in the middle of the range.
The series is highly variable year to year, so single readings are best treated with caution.
Life science patents granted, by filing office in Monaco, year by year
| Year | patents | Change |
|---|---|---|
| 1980 | 19 patents | — |
| 1981 | 16 patents | -15.8% |
| 1982 | 18 patents | +12.5% |
| 1983 | 8 patents | -55.6% |
| 1984 | 14 patents | +75.0% |
| 1985 | 15 patents | +7.1% |
| 1986 | 17 patents | +13.3% |
| 1987 | 17 patents | +0.0% |
| 1988 | 12 patents | -29.4% |
| 1989 | 25 patents | +108.3% |
| 1990 | 19 patents | -24.0% |
| 1991 | 11 patents | -42.1% |
| 1992 | 7 patents | -36.4% |
| 1993 | 17 patents | +142.9% |
| 1994 | 5 patents | -70.6% |
| 1995 | 2 patents | -60.0% |
| 1996 | 6 patents | +200.0% |
| 1997 | 2 patents | -66.7% |
| 1998 | 4 patents | +100.0% |
| 1999 | 0 patents | -100.0% |
| 2000 | 0 patents | — |
| 2001 | 2 patents | — |
| 2002 | 0 patents | -100.0% |
| 2003 | 2 patents | — |
| 2004 | 1 patents | -50.0% |
| 2005 | 2 patents | +100.0% |
| 2006 | 3 patents | +50.0% |
| 2007 | 1 patents | -66.7% |
| 2008 | 0 patents | -100.0% |
| 2009 | 0 patents | — |
| 2010 | 0 patents | — |
| 2011 | 2 patents | — |
| 2012 | 0 patents | -100.0% |
| 2013 | 1 patents | — |
| 2014 | 0 patents | -100.0% |
| 2015 | 0 patents | — |
| 2016 | 2 patents | — |
| 2017 | 2 patents | +0.0% |
| 2018 | 2 patents | +0.0% |
| 2019 | 2 patents | +0.0% |
| 2020 | 2 patents | +0.0% |
| 2021 | 1 patents | -50.0% |
| 2022 | 0 patents | -100.0% |
| 2023 | 1 patents | — |
Monaco compared with similar countries
- Monaco's 1 patents is below the median for high income countries, which is 28 patents, 4% of the median. (43 countries reporting)
- Monaco's 1 patents is below the median for Europe & Central Asia, which is 25.5 patents, 4% of the median. (40 countries reporting)
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 1980s | 16.1 patents | 8 patents | 25 patents | 10 |
| 1990s | 7.3 patents | 0 patents | 19 patents | 10 |
| 2000s | 1.1 patents | 0 patents | 3 patents | 10 |
| 2010s | 1.1 patents | 0 patents | 2 patents | 10 |
| 2020s | 1 patents | 0 patents | 2 patents | 4 |
Countries ranked near Monaco
- 43 Croatia 2 patents compare
- 43 Estonia 2 patents compare
- 43 Israel 2 patents compare
- 46 Ukraine 1 patents compare
- 48 Argentina 0 patents compare
- 48 Bosnia and Herzegovina 0 patents compare
- 48 Chile 0 patents compare
- 48 Egypt 0 patents compare
- 48 Hong Kong 0 patents compare
- 48 Iceland 0 patents compare
- 48 Indonesia 0 patents compare
- 48 Italy 0 patents compare
- 48 Kenya 0 patents compare
- 48 Malta 0 patents compare
- 48 Mexico 0 patents compare
- 48 Mongolia 0 patents compare
- 48 Montenegro 0 patents compare
- 48 Nicaragua 0 patents compare
- 48 Philippines 0 patents compare
- 48 Russia 0 patents compare
- 48 San Marino 0 patents compare
- 48 Singapore 0 patents compare
- 48 Tajikistan 0 patents compare
- 48 Turkey 0 patents compare
- 48 USSR 0 patents compare
- 48 Vietnam 0 patents compare
- 48 Zimbabwe 0 patents compare
More science & technology data for Monaco
- Mobile landline subscriptions, per unit of GDP 0 units per US$ of GDP (2024)
- Mobile landline subscriptions, gaps filled 107.4 (2024)
- Mobile cellular subscriptions by country, per capita 1.07 units per person (2024)
- Mobile cellular subscriptions by country, per unit of GDP 0 units per US$ of GDP (2024)
- Mobile cellular subscriptions by country, gaps filled 41,490 (2024)
- Mobile cellular subscriptions by country, per square kilometre 19,452 units per square kilometre (2023)
- Mobile landline subscriptions, annual growth rate 3.21 % change on previous year (2024)
- Mobile cellular subscriptions by country, annual growth rate 2.35 % change on previous year (2024)
- Patent applications, nonresidents, gaps filled 2 (2023)
- Patent applications, nonresidents 2 (2023)
Frequently asked questions
- What is life science patents granted, by filing office in Monaco?
- Life science patents granted, by filing office in Monaco was 1 patents in 2023, according to World Intellectual Property Organization (WIPO) (2025) – processed by Our World in Data.
- What is the highest life science patents granted, by filing office recorded in Monaco?
- The highest recorded value was 25 patents in 1989.
- What is the lowest life science patents granted, by filing office recorded in Monaco?
- The lowest recorded value was 0 patents in 1999.
- How does Monaco rank for life science patents granted, by filing office?
- Monaco ranks 46th out of 70 countries with data for 2023.
- Is life science patents granted, by filing office rising or falling in Monaco?
- Over the last ten years it is unchanged. The long-run trend across the full record is volatile.
- Where does this Monaco data come from?
- The figures come from World Intellectual Property Organization (WIPO) (2025) – processed by Our World in Data, published as part of Life science patents granted, by filing office. Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 44 observations, free to reuse under CC BY 4.0 (Our World in Data).
About this data
Patents granted within the fields of medical technology, biotechnology, and pharmaceuticals by filing office. These patents cover a wide range of innovations, such as medical devices, diagnostic methods, genetic engineering techniques, biotechnological processes and new drugs.